Phillip Mertz
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Phillip P.
Mertz is the founder of Secure Open Solutions.
Mr. Mertz is Chief Executive Officer at Subtle Technologies, Independent Director at Alpha Cognition, Inc., and Partner at Mertz Holdings.
Mr. Mertz was Director at Alpha Cognition, Inc. Mr. Mertz completed undergraduate studies at Harvard University in 2006.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALPHA COGNITION INC 0,62 % | 24.04.2026 | 135 503 ( 0,62 % ) | 838 764 $ | 31.05.2026 |
ALPHA COGNITION, INC. 13,95 % | 24.04.2026 | 44 160 ( 13,95 % ) | 273 350 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALPHA COGNITION INC. | Direktor/Vorstandsmitglied | 18.03.2021 |
Secure Open Solutions | Gründer | - |
Subtle Technologies | Vorstandsvorsitzender | - |
Mertz Holdings
Mertz Holdings Financial ConglomeratesFinance Functions as an investment holding company | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treating alzheimer disease and amyotrophic lateral sclerosis | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mertz Holdings
Mertz Holdings Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treating alzheimer disease and amyotrophic lateral sclerosis | Health Technology |
Alpha Cognition, Inc.
Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
Secure Open Solutions | |
Subtle Technologies |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen